Killing ‘Zombie’ Immune Cells to Heal an Aging Liver

Key Takeaways

• “Zombie” immune cells can sabotage metabolic health. In mice, a large share of liver macrophages slipped into a senescent, pro‑inflammatory state that disrupted tissue function.
• Cholesterol overload helps create these cells. Prolonged exposure to excess LDL cholesterol pushed otherwise healthy macrophages into a senescent, inflammatory phenotype, hinting that high-fat, high‑cholesterol diets may accelerate biological aging across multiple organs.
• Clearing senescent macrophages reversed liver damage—without changing diet. When researchers selectively killed off these cells, liver inflammation and fat accumulation dropped, organ size and color normalized, and body weight fell, even though the mice kept eating the same unhealthy food.

A New Culprit: Senescent Macrophages

Cellular senescence usually brings to mind fibroblasts or epithelial cells that stop dividing and start secreting inflammatory factors. This study shows that macrophages—the immune cells that patrol tissues and clear debris—can also become truly senescent, not just temporarily activated. The team identified a distinct signature: macrophages expressing both p21 (a cell‑cycle inhibitor) and TREM2 (a receptor linked to lipid handling) were no longer doing normal cleanup work but were still pumping out inflammatory signals.

In young mice, only a small fraction of liver macrophages carried this p21‑TREM2 profile, but in older animals, that fraction exploded to 60–80%, mirroring the rise in chronic liver inflammation with age. When healthy macrophages were bathed in high levels of LDL cholesterol in the lab, they adopted the same senescent signature and inflammatory secretions, suggesting prolonged lipid overload can “age” these cells prematurely. That offers a mechanistic bridge between overnutrition, chronic inflammation, and organ damage.

Killing “Zombie” Cells to Heal a Metabolic Organ

To see whether these cells were just bystanders or drivers, the researchers treated mice on a high‑fat, high‑cholesterol diet with a senolytic drug (ABT‑263) designed to selectively eliminate senescent cells. The results were striking. Livers that had become enlarged and yellowish with fat shrank back toward normal size and color; liver weight dropped from roughly 7% of body weight toward a healthier 4–5%. Body weight fell by about 25% even though the diet didn’t change.

Histology and molecular readouts showed less fat accumulation and lower inflammatory signaling, indicating real tissue repair rather than cosmetic shrinkage. Importantly, when the team examined human liver transcriptomic data, the same senescent macrophage signature was elevated in samples from people with fatty liver compared with healthy controls. That doesn’t prove causation in humans, but it suggests the same biology is present and may be clinically relevant.

Longevity Lens: Targeting a Shared Aging Mechanism

This work fits neatly into the geroscience idea that a few core aging processes drive many age‑related diseases. Here, one such process is macrophage senescence: a small population of dysfunctional immune cells that clogs the system like “stalled cars on the freeway,” amplifying inflammation and metabolic stress far out of proportion to their numbers. If these senescent immune cells turn out to be a shared upstream driver of inflammation and tissue damage in multiple organs, then learning how to safely clear or reprogram them could offer broad benefits across the body.

There are important caveats. The senolytic used in this study is too toxic for routine human use, so safer, more selective ways of clearing or reprogramming senescent macrophages are needed. And mouse reversal of liver damage on an extreme diet doesn’t guarantee the same response in people. Still, the story is encouraging: it points to a modifiable cellular target—zombie-like immune cells driven in part by excess cholesterol—that might be addressed both with future drugs and with present‑day choices around diet, lipid levels, and chronic inflammation.

References: 

Ivan A. Salladay-Perez, Itzetl Avila, Lizeth Estrada, Andreea C. Alexandru, Cristian Ponce, Anika Dhingra, Grasiela Torres, Christina Y. Deng, Ronak Hegde, Julia Gensheimer, Abhijit Kale, Indra Heckenbach, Simon Hui, Chantle Edillor, Jose A. Soto, Alexander J. Napior, Isaiah Little, Mark Larsen, Jacob Rose, Lia Farahi, Edwin D. J. Lopez Gonzalez, Matthew R. Krieger, Kushan Chowdhury, Mridul Sharma, Yuming Jiang, Kevin Williams, Morten Scheibye-Knudsen, Carla M. Koehler, Jesse G. Meyer, Julia J. Mack, Charles Brenner, Steven J. Bensinger, Cyril Lagger, João Pedro de Magalhães, Birgit Schilling, Rajat Singh, Eric Verdin, Aldons J. Lusis, Anthony J. Covarrubias. p21 TREM2 senescent macrophages fuel inflammaging and metabolic dysfunction-associated... Nature Aging, 2026; DOI: 10.1038/s43587-026-01101-6